ASPIRE BIOPHARMA HOLDINGS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ASPIRE BIOPHARMA HOLDINGS, INC. payments for repurchase of common stock for the quarter ending 2024-12-31 was $0.00.
- ASPIRE BIOPHARMA HOLDINGS, INC. payments for repurchase of common stock for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- ASPIRE BIOPHARMA HOLDINGS, INC. payments for repurchase of common stock for the quarter ending 2023-12-31 was $0.00.
- ASPIRE BIOPHARMA HOLDINGS, INC. payments for repurchase of common stock for the quarter ending 2023-09-30 was $632.97K.
- ASPIRE BIOPHARMA HOLDINGS, INC. payments for repurchase of common stock for fiscal 2024 was $13.78M, a 95.16% decline from fiscal 2023.
- ASPIRE BIOPHARMA HOLDINGS, INC. payments for repurchase of common stock for fiscal 2023 was $284.92M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $13.78M 10-K · filed 2025-04-07 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-07 | $284.92M 10-K · filed 2025-04-07 |
| 2023-09-30 | $632.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |